美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0409-2344-02	0409-2344	HUMAN PRESCRIPTION DRUG	DOBUTAMINE	DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050629	N/A	ANDA	ANDA074086	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	12.5 mg/mL	10 VIAL, SINGLE-DOSE in 1 TRAY (0409-2344-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-2344-62)
0409-2344-01	0409-2344	HUMAN PRESCRIPTION DRUG	DOBUTAMINE	DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050803	N/A	ANDA	ANDA074086	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	12.5 mg/mL	1 VIAL, SINGLE-DOSE in 1 CARTON (0409-2344-01) / 20 mL in 1 VIAL, SINGLE-DOSE
0409-2344-88	0409-2344	HUMAN PRESCRIPTION DRUG	DOBUTAMINE	DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20050430	N/A	ANDA	ANDA074086	Hospira, Inc.	DOBUTAMINE HYDROCHLORIDE	12.5 mg/mL	10 VIAL, SINGLE-DOSE in 1 TRAY (0409-2344-88) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-2344-68)
51662-1337-1	51662-1337	HUMAN PRESCRIPTION DRUG	DOBUTAMINE	DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20181126	N/A	ANDA	ANDA074086	HF Acquisition Co LLC, DBA HealthFirst	DOBUTAMINE HYDROCHLORIDE	12.5 mg/mL	20 mL in 1 VIAL, SINGLE-DOSE (51662-1337-1)
51662-1337-3	51662-1337	HUMAN PRESCRIPTION DRUG	DOBUTAMINE	DOBUTAMINE	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	20220612	N/A	ANDA	ANDA074086	HF Acquisition Co LLC, DBA HealthFirst	DOBUTAMINE HYDROCHLORIDE	12.5 mg/mL	10 POUCH in 1 CASE (51662-1337-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2) / 20 mL in 1 VIAL, SINGLE-DOSE